In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A

Jeong-Sun Nam, Daewon Yoon, Yujin Kim, Su-Young Kim, Jae-Young Kim, Yoonkyoung Cha, Joon Seok, Beom Joon Kim · 2026

Read In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A by Jeong-Sun Nam, Daewon Yoon, Yujin Kim, Su-Young Kim, Jae-Young Kim, Yoonkyoung Cha, Joon Seok, Beom Joon Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13211361.txt.

Description

Jeong-Sun Nam and co-authors compare two types of botulinum toxin, E and A, in living mice, in a 2026 study. Both block nerve signals to muscle and cause temporary paralysis. Type A is the standard in medicine, but repeat use can leave lasting wasting, scarring, and inflammation in muscle. Type E is known to act faster and wear off sooner, yet its safety record was thin.

In hairless mice, type E peaked on day three and wore off fully by day thirty-five. Type A peaked on day seven and had recovered only a fifth of normal strength by day thirty-five. Type E's dips in muscle size and its scarring faded by the end, while type A left lasting wasting and more inflammation-linked cells. Neither toxin spread to nearby muscles or changed body weight.

Catalog record

CREATORJeong-Sun Nam, Daewon Yoon, Yujin Kim, Su-Young Kim, Jae-Young Kim, Yoonkyoung Cha, Joon Seok, Beom Joon Kim
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13211361

Browse the full library · About the Tower of Babel